Accelerating Medicines Partnership

GPTKB entity

Predicate	Object
gptkbp:instanceOf	public-private partnership
gptkbp:abbreviation	gptkb:AMP
gptkbp:collaboratesWith	gptkb:Foundation_for_the_National_Institutes_of_Health academic institutions multiple pharmaceutical companies
gptkbp:country	gptkb:United_States
gptkbp:firstReleased	2014
gptkbp:focusArea	gptkb:Alzheimer's_disease gptkb:Parkinson's_disease gptkb:Systemic_lupus_erythematosus gptkb:Type_2_diabetes Schizophrenia Rheumatoid arthritis
gptkbp:fundedBy	public and private sectors
gptkbp:goal	identify and validate promising biological targets for therapeutics
https://www.w3.org/2000/01/rdf-schema#label	Accelerating Medicines Partnership
gptkbp:launched	gptkb:National_Institutes_of_Health gptkb:U.S._Food_and_Drug_Administration non-profit organizations biopharmaceutical companies
gptkbp:purpose	accelerate the discovery of new therapies
gptkbp:website	https://www.nih.gov/research-training/accelerating-medicines-partnership-amp
gptkbp:bfsParent	gptkb:Foundation_for_the_National_Institutes_of_Health
gptkbp:bfsLayer	6